Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Summarize the 2023 performance of World Ex Us dividend ETFs, highlighting key drivers, top contributors, and implications for investors.
22,394 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
As Netflix prepares to report earnings after the bell, investors are dialed in on one question that could shape the s...
A major institutional stake in TTMI has sparked fresh debates about the stock's risk and reward. This guide breaks do...
Urban Outfitters’ namesake stores are lifting results as fourth-quarter earnings beat expectations, signaling a broad...
Premarket gains in Coherent, LUMENTUM and AAOI reflect a renewed wave of optimism for optics amid NVIDIA's GTC expect...
A new analysis puts the value of unpaid caregiving at $683 billion, highlighting the economic weight carried by women...
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
KB Home's Q1 2026 results shed light on the company’s earnings trajectory and the housing market dynamics. This guide...
Alphabet’s Q1 2026 results show a rapid profit pace that dwarfs Meta’s earnings, underscoring a widening gap in AI-dr...
TSMC delivered a stronger-than-expected Q1 2026, lifting full-year targets as AI demand powers the cycle, fueling the...
A growing wave of market voices warns that the flood of easy investing access can erode returns. Carlson says many in...
IBM led a narrow rally in a mixed tech session, jumping 8% while Oracle, Cisco, and HPE drifted. The move raises ques...